Arcutis Biotherapeutics Financial Overview
Arcutis Biotherapeutics's market cap is currently $3.49B. The company's EPS TTM is $0.06; its P/E ratio is -79.94; Arcutis Biotherapeutics is scheduled to report earnings on October 1, 2025, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
